DongFang,Li – Trademark Portfolio

Entity Type: 01

DongFang,Li holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 25 (Clothing) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include ICNESS and AGS NOVELTIES. The owner is based in Luoding.

No.20, Sitiaowei, Liangnan Village 

Community, Liangtang Town

Luoding 999001 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

DongFang,Li's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

25
Clothing (1 filing)

Clothing, footwear, headgear

28
Toys & Sporting Goods (1 filing)

Games and playthings; gymnastic and sporting articles; decorations for Christmas trees

Frequently Asked Questions

How many trademarks does DongFang,Li have?

DongFang,Li has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 1 cancelled.

What trademark classes does DongFang,Li file in?

DongFang,Li files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 25 (Clothing), Class 28 (Toys & Sporting Goods). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are DongFang,Li's most well-known trademarks?

DongFang,Li's registered trademark portfolio includes well-known marks such as ICNESS and AGS NOVELTIES. These are among 2 currently registered trademarks in the portfolio.

What is DongFang,Li's trademark registration success rate?

DongFang,Li has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.